140
Stroncek DF, Jin P, McKenna DH, Takanashi M, Fontaine MJ, Pati S, Schäfer R, Peterson E, Benedetti E, Reems J.
Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Front. Cell Dev. Biol., 16 June 2020.
139
Turner G, Gniadek, Baye J, Pena R, Warner P, Fung M, Beaudin L, Dunckley H, Gandhi M, Gathof B, Hsu S, Klohe E, Marcus N, Bamert R, Sims S, Takanashi M, Wendel S, Cohn CS, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
The effect of serum pretreatment regimens for the detection of HLA class I antibodies in platelet-refractory patients.
Transfusion. 2020 Mar;60(3):488-497.
138
Seheult JN, Dunbar NM, Hess JR, Tuott EE, Bahmanyar M, Campbell J, Fontaine M, Khan J, Ko A, Mi J, Murphy MF, Nykoluk T, Poission J, Raval JS, Shih A, Sperry JL, Staves J, Wong M, Yan MTS, Ziman A, Yazer MH, Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
ransfusion of blood components containing ABO-incompatible plasma does not lead to higher mortality in civilian trauma patients.
Transfusion. 2020 Sep 9. doi: 10.1111/trf.16008. Online ahead of print.
137
Yazer MH, Spinella PC, Doyle L, Kaufman RM, Dunn R, Hess JR, Filho LA, Fontaine M, Gathofv B, Jackson B, Murphy MF, Pasion J, Raval JS, Rosinski K, Seheult J, Shih AW, Sperry J, Staves J, Tuott EE, Ziman A, Triulzi DJ, Biomedical Excellence for Safer Transfusion Collaborative.
Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere With Most ABO Typings.
Anesthesiology. 2020;132(3):525-534.
136
Zalpuri S, Romeijn B, Allara E, Goldman M , Kamel H, Gorlin J, Vassallo R, Grégoire Y, Goto N, Flanagan P, Speedy J, Buser A, Kutner JM , Magnussen K, Castrén J, Culler L, Sussmann H, Prinsze FJ, Belanger K, Compernolle V, Tiberghien P, Cardenas JM, Gandhi MJ, West KA, Lee C-K, James S, Wells D, Sutor LJ, Wendel S, Coleman M, Seltsam A, Roden K, Steele WR, Bohonek M, Alcantara R, Di Angelantonio E, van den Hurk K, BEST Collaborative Study Group.
Variations in Hemoglobin Measurement and Eligibility Criteria Across Blood Donation Services Are Associated With Differing Low-Hemoglobin Deferral Rates: A BEST Collaborative Study.
Transfusion. 2020 Mar;60(3):544-552.
135
Delaney M, Apelseth TO, Bonet Bub C, Cohn CS, Dunbar NM, Mauro Kutner J, Murphy M, Perelman I, Selleng K, Staves J, Wendel S, Ziman A; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Red-blood-cell alloimmunization and prophylactic antigen matching for transfusion in patients with warm autoantibodies.
Vox Sang. 2020 Apr 6. doi: 10.1111/vox.12914. Online ahead of print.
134
Fontaine MJ, Selogie E, Stroncek D, McKenna D, Szczepiorkowski ZM, Takanashi M, Garritsen H, Girdlestone J, Reems JA; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Variations in novel cellular therapy products manufacturing.
Cytotherapy. 2020 Jun;22(6):337-342.
133
Masser BM, Wright S, Germain M, Grégoire Y, Goldman M, O'Brien SF, Kamel H, Bravo M, Merz EM,, van den Hurk K, Prinsze F, Takanashi M, Wilder Z, Shaz B; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
The impact of age and sex on first-time donor return behavior.
Transfusion. 2020 Jan;60(1):84-93.
132
Shih AW, Apelseth TO, Cardigan R, Marks DC, Bégué S, Greinacher A, de Korte D, Seltsam A, Shaz BH, Wikman A, Barty RL, Heddle NM, Acker JP; QMiP Investigators on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data.
Vox Sang. 2019 Nov;114(8):783-794.
131
Yazer MH, Dunbar NM, Thomas J, Nunes E, Murphy MF; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Transfusion-associated circulatory overload risk mitigation: survey on hospital policies for compliance with AABB Standard 5.9.17.
Transfusion. 2019 Sep;59(9):2833-2839.
